1982
DOI: 10.1073/pnas.79.24.7951
|View full text |Cite
|
Sign up to set email alerts
|

Peptaibol antibiotics: a study on the helical structure of the 2-9 sequence of emerimicins III and IV.

Abstract: AESThACT ISolution conformations of the protected 2-9 segment of the peptaibol antibiotics emerimicins m and IV [a-aminoisobutyric acid (Aib)]3r-Val-Gly-L.Lkeu(b)2 and the related short _se s b oxy(Ab)Val-OMe and benzwoxy4Ab)jAal.GlyOMe have been investigated bycirculardichroism studies. For.the latter two cpounds the-structural preferences in the solid state have been assayed byx-ray diffraction analyses. The exerimental data described here, along with these previously reported, support the view that the shor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
87
0

Year Published

1986
1986
2014
2014

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 182 publications
(87 citation statements)
references
References 17 publications
0
87
0
Order By: Relevance
“…Specifically, His 21 substitution by Ala and Glu provided a significant effect on solubility (i.e., approximately fourfold decreased and fourfold increased, respectively). Incorporation of Glu 21 and modification of Leu 26 by Cba and C-terminal extension with Ala-Ala yielded AcLeu 17 -Thr-Phe-cyclo(R8-Glu-Tyr-Trp-Ala-Gln-Cba-S5)-Ser-AlaAla 30 -NH 2 (ATSP-7041), which exhibited high affinity binding to both MDM2 (K i = 0.9 nM) and MDMX (K i = 7 nM) (Fig. 1A).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Specifically, His 21 substitution by Ala and Glu provided a significant effect on solubility (i.e., approximately fourfold decreased and fourfold increased, respectively). Incorporation of Glu 21 and modification of Leu 26 by Cba and C-terminal extension with Ala-Ala yielded AcLeu 17 -Thr-Phe-cyclo(R8-Glu-Tyr-Trp-Ala-Gln-Cba-S5)-Ser-AlaAla 30 -NH 2 (ATSP-7041), which exhibited high affinity binding to both MDM2 (K i = 0.9 nM) and MDMX (K i = 7 nM) (Fig. 1A).…”
Section: Methodsmentioning
confidence: 99%
“…Stapled peptides were first described as a novel approach to creating macrocyclic α-helical peptides through the addition of an all-hydrocarbon cross-link between two α−methyl-substituted amino acids having terminal olefin side-chains to enable ringclosing metathesis using Grubbs ruthenium catalyst (17,18). Historically, it is important to recognize the precedence macrocyclization of the O-allyl-modified peptides by the Grubbs research group (19,20) as well as intrinsic helical-inducing properties of linear peptides incorporating α−methyl-substituted amino acids by the Toniolo research group (21,22). Relative to a previously published stapled peptide, SAH-p53-8 (3,15), the limited biological potency determined in our cellular assays using more stringent physiologic conditions (i.e., in the presence of 10% serum) inspired us to tackle this highly important cancer target and advance a more rigorously tested preclinical lead compound relative to both in vitro and in vivo efficacy.…”
mentioning
confidence: 99%
“…More recently, by theoretical (7)(8)(9)(10)(11) as well as experimental (12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27) investigations, it has been shown that the 4,q, angles ofthe achiral a-aminoisobutyric acid residue (Aib), the prototype of Caa-dialkylated a-amino acids, are restricted to values near those associated either with right-or left-handed a-or 310-helices, unless it is part of a strained cyclic compound (28). The x-ray diffraction structures of aaminoisobutyric acid homopeptides to the pentamer have provided examples of short (less than two complete turns) 310-helical conformations in the solid state (14,15,22,23).…”
mentioning
confidence: 99%
“…The sequence Aib-Aib-Aib-Ala represents a segment of the naturally occurring peptaibol antibiotic peptides containing -aminoisobutyric acid (Aib) and a C-terminal -amino alcohol (Brü ckner & Graf, 1983;Benedetti et al, 1982) such as trichotoxin (Brü ckner et al, 1985). We present here the crystal structure of Z-Aib 3 -l-Ala-OtBu containing this tetrapeptide.…”
Section: Introductionmentioning
confidence: 99%